期刊文献+

粒细胞缺乏伴口腔溃疡导致败血症2例并文献复习 被引量:1

Septicemia resulting from agranulocytosis with oral ulcer:2 cases report and literature review
原文传递
导出
摘要 粒细胞缺乏伴口腔溃疡临床常见,特别是接受放化疗或免疫抑制剂治疗的恶性肿瘤、血液系统疾病患者。口腔溃疡合并感染,除局部感染表现外,其引起同源性败血症的案例少见。我们报告粒细胞缺乏伴口腔溃疡继发同源性败血症患者2例如下。1病例资料例1,女,22岁,因"牙龈出血1周"入院,确诊为急性重型再生障碍性贫血。 To investigate clinical features,preventions,therapies in patients with septicemia resulting from agranulocytosis with oral ulcer,we analyzed the pathogenesis, clinical manifestations,laboratory tests and therapies of 2 cases with septicemia resulting from agranulocytosis and oral ulcer,and reviewed the relevant literature. Of 2 cases,one patient was confirmed acute severe aplastic anemia,the other one with acute lymphoid leukemia received haploid allogeneic peripheral blood stem cell transplantation. Both of 2 cases had onset of fever with severe oral ul- cer under the condition of agranulocytosis. Both of them found cultivated bacteria from oral and blood culture (bilateral double bottle) was done at the same time. The culture result in one case was stenotrophomonas maltophilia, and the other one was candida tropicalis. According to the drug sensitivity tests, the anti-infection therapeutic regi- men was adjusted. Both of 2 patients were discharged with improved conditions. There was potential possibility that severe oral ulcer with systemic infections could result in septicemia during agranulocytosis phase. Oral secretion and blood culture would be helpful in guiding our treatment. Once the pathogenesis was confirmed, adjusting anti-infection therapeutic regimen according to the drug sensitivity tests would improve the conditions of patients.
出处 《临床血液学杂志》 CAS 2017年第2期233-235,共3页 Journal of Clinical Hematology
基金 国家自然科学基金(No:81270652 81570175)
关键词 粒细胞缺乏 口腔溃疡 败血症 预防 治疗 agranulocytosis oral ulcer septicemia prevention therapy
作者简介 通信作者:仇红霞,E-mail:qhx9805@126.com
  • 相关文献

参考文献8

二级参考文献90

  • 1张致平.抗耐药菌药物研究进展[J].中国抗生素杂志,2005,30(7):430-440. 被引量:12
  • 2田同荣.恶性肿瘤患者化疗引起口腔黏膜炎的危险因素分析[J].中国肿瘤临床与康复,2007,14(2):186-189. 被引量:20
  • 3胡必杰.转变观念 改革系统 共创医院感染“零宽容”[J].中华内科杂志,2007,46(9):708-709. 被引量:30
  • 4Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. M100-S21. Wayne, PA :CLSI,2011.
  • 5中华人民共和国卫生部.卫办医政发[2011]5号.多重耐药菌医院感染预防与控制技术指南(试行).2011-01-17.
  • 6European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1. 2010-04-27.
  • 7Bochud PY, Bonten M, Marchetti O, et al. Antimicrobial therapy for patients with severe sepsis and septic shock:an evidence-based review. Crit Care Med, 2004, 32:495-512.
  • 8Smeya Y, Yamaguchi A, Sawai T. A novel glycylcycline, 9-(N, N-dimethylglycylamido) -6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal- tetracycline/H + antiporter. Antimicrob Agents Chemother, 1995, 39:247-249.
  • 9Zhanel GG, Karlowsky JA, Rubinstein E, et al. Tigecycline : a novel glycylcycline antibiotic. Expert Rev Anti Infect Ther, 2006, 4:9-25.
  • 10Elting LS, Cooksley C,Chambers M,et al. The burdens of cancer ther-apy. Clinical and economic outcomes of chemotherapy - induced mu-cositis[J]. Cancer, 2003,98(7) :1531 -1539.

共引文献354

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部